Search Results

There are 8039164 results for: content related to: The Characterization of 3,4-Dimethylmethcathinone (3,4-DMMC)

  1. Cathinone derivatives: A review of their chemistry, pharmacology and toxicology

    Drug Testing and Analysis

    Volume 3, Issue 7-8, July - August 2011, Pages: 439–453, John P. Kelly

    Version of Record online : 13 JUL 2011, DOI: 10.1002/dta.313

  2. You have free access to this content
    The preclinical pharmacology of mephedrone; not just MDMA by another name

    British Journal of Pharmacology

    Volume 171, Issue 9, May 2014, Pages: 2251–2268, A R Green, M V King, S E Shortall and K C F Fone

    Version of Record online : 11 APR 2014, DOI: 10.1111/bph.12628

  3. The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone)

    Drug Testing and Analysis

    Volume 3, Issue 7-8, July - August 2011, Pages: 454–463, Paul I. Dargan, Roumen Sedefov, Ana Gallegos and Dr David M. Wood

    Version of Record online : 13 JUL 2011, DOI: 10.1002/dta.312

  4. You have free access to this content
    Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone

    British Journal of Pharmacology

    Volume 167, Issue 2, September 2012, Pages: 407–420, Raul López-Arnau, Jose Martínez-Clemente, David Pubill, Elena Escubedo and Jorge Camarasa

    Version of Record online : 22 AUG 2012, DOI: 10.1111/j.1476-5381.2012.01998.x

  5. Deaths of individuals aged 16–24 years in the UK after using mephedrone

    Human Psychopharmacology: Clinical and Experimental

    Volume 30, Issue 4, July 2015, Pages: 225–232, Barbara Loi, John Martin Corkery, Hugh Claridge, Christine Goodair, Stefania Chiappini, Carla Gimeno Clemente and Fabrizio Schifano

    Version of Record online : 28 JUL 2015, DOI: 10.1002/hup.2423

  6. Is there any difference in patterns of use and psychiatric symptom status between injectors and non-injectors of mephedrone?

    Human Psychopharmacology: Clinical and Experimental

    Volume 30, Issue 4, July 2015, Pages: 233–243, Máté Kapitány-Fövény, Barbara Mervó, Máté Kertész, Ornella Corazza, Judit Farkas, Gyöngyi Kökönyei, Róbert Urbán and Zsolt Demetrovics

    Version of Record online : 28 JUL 2015, DOI: 10.1002/hup.2490

  7. Mephedrone, new kid for the chop?

    Addiction

    Volume 106, Issue 1, January 2011, Pages: 154–161, Adam R. Winstock, Luke R. Mitcheson, Paolo Deluca, Zoe Davey, Ornella Corazza and Fabrizio Schifano

    Version of Record online : 23 AUG 2010, DOI: 10.1111/j.1360-0443.2010.03130.x

  8. You have free access to this content
    Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia

    British Journal of Pharmacology

    Volume 168, Issue 4, February 2013, Pages: 966–977, SE Shortall, AR Green, KM Swift, KCF Fone and MV King

    Version of Record online : 24 JAN 2013, DOI: 10.1111/j.1476-5381.2012.02236.x

  9. Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 728–738, Kayla N. Ellefsen, Sébastien Anizan, Marisol S. Castaneto, Nathalie A. Desrosiers, Thomas M. Martin, Kevin L. Klette and Marilyn A. Huestis

    Version of Record online : 21 MAR 2014, DOI: 10.1002/dta.1633

  10. You have free access to this content
    Mephedrone, Methylone and 3,4-Methylenedioxypyrovalerone (MDPV) Induce Conditioned Place Preference in Mice

    Basic & Clinical Pharmacology & Toxicology

    Volume 115, Issue 5, November 2014, Pages: 411–416, Louise Karlsson, Mikael Andersson, Robert Kronstrand and Fredrik C. Kugelberg

    Version of Record online : 6 MAY 2014, DOI: 10.1111/bcpt.12253

  11. GHB and synthetic cathinones: clinical effects and potential consequences

    Drug Testing and Analysis

    Volume 3, Issue 9, September 2011, Pages: 552–559, Laurent Karila and Michel Reynaud

    Version of Record online : 2 DEC 2010, DOI: 10.1002/dta.210

  12. Identification and characterization of an imidazolium by-product formed during the synthesis of 4-methylmethcathinone (mephedrone)

    Drug Testing and Analysis

    Volume 7, Issue 10, October 2015, Pages: 894–902, John D. Power, Pierce Kavanagh, Gavin McLaughlin, John O'Brien, Brian Talbot, Michael Barry, Brendan Twamley, Geraldine Dowling and Simon D. Brandt

    Version of Record online : 1 APR 2015, DOI: 10.1002/dta.1789

  13. You have free access to this content
    Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3 receptors and BDNF in place preference acquisition

    British Journal of Pharmacology

    Volume 172, Issue 20, October 2015, Pages: 4970–4984, Andrés Ciudad-Roberts, Jorge Camarasa, Carlos J. Ciudad, David Pubill and Elena Escubedo

    Version of Record online : 9 OCT 2015, DOI: 10.1111/bph.13266

  14. You have free access to this content
    Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats

    British Journal of Pharmacology

    Volume 172, Issue 3, February 2015, Pages: 883–894, Ryan A Gregg, Michael H Baumann, John S Partilla, Julie S Bonano, Alexandre Vouga, Christopher S Tallarida, Venkata Velvadapu, Garry R Smith, M Melissa Peet, Allen B Reitz, S Stevens Negus and Scott M Rawls

    Version of Record online : 15 DEC 2014, DOI: 10.1111/bph.12951

  15. You have full text access to this OnlineOpen article
    Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters

    British Journal of Pharmacology

    Volume 173, Issue 17, September 2016, Pages: 2657–2668, F P Mayer, L Wimmer, O Dillon-Carter, J S Partilla, N V Burchardt, M D Mihovilovic, M H Baumann and H H Sitte

    Version of Record online : 31 JUL 2016, DOI: 10.1111/bph.13547

  16. Changes in patterns of injecting drug use in Hungary: a shift to synthetic cathinones

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 825–831, Anna Péterfi, Anna Tarján, Gergely Csaba Horváth, Tamás Csesztregi and Adrienn Nyírády

    Version of Record online : 1 APR 2014, DOI: 10.1002/dta.1625

  17. You have free access to this content
    Pharmacological characterization of designer cathinones in vitro

    British Journal of Pharmacology

    Volume 168, Issue 2, January 2013, Pages: 458–470, LD Simmler, TA Buser, M Donzelli, Y Schramm, L-H Dieu, J Huwyler, S Chaboz, MC Hoener and ME Liechti

    Version of Record online : 20 DEC 2012, DOI: 10.1111/j.1476-5381.2012.02145.x

  18. You have free access to this content
    Mephedrone: use, subjective effects and health risks

    Addiction

    Volume 106, Issue 11, November 2011, Pages: 1991–1996, Adam Winstock, Luke Mitcheson, John Ramsey, Susannah Davies, Malgorzata Puchnarewicz and John Marsden

    Version of Record online : 27 JUL 2011, DOI: 10.1111/j.1360-0443.2011.03502.x

  19. Using poisons information service data to assess the acute harms associated with novel psychoactive substances

    Drug Testing and Analysis

    Volume 6, Issue 7-8, July-August 2014, Pages: 850–860, D. M. Wood, S. L. Hill, S. H. L. Thomas and P. I. Dargan

    Version of Record online : 15 MAY 2014, DOI: 10.1002/dta.1671

  20. You have free access to this content
    Analyses of second-generation ‘legal highs’ in the UK: Initial findings

    Drug Testing and Analysis

    Volume 2, Issue 8, August 2010, Pages: 377–382, Simon D. Brandt, Harry R. Sumnall, Fiona Measham and Jon Cole

    Version of Record online : 5 AUG 2010, DOI: 10.1002/dta.155